These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23448846)

  • 21. Assessment of the association between blood pressure control and health care resource use.
    Lapuerta P; Simon T; Smitten A; Caro J;
    Clin Ther; 2001 Oct; 23(10):1773-82. PubMed ID: 11726010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial.
    Feldman RD; Zou GY; Vandervoort MK; Wong CJ; Nelson SA; Feagan BG
    Hypertension; 2009 Apr; 53(4):646-53. PubMed ID: 19237683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
    Bangalore S; Gong Y; Cooper-DeHoff RM; Pepine CJ; Messerli FH
    J Am Coll Cardiol; 2014 Aug; 64(8):784-93. PubMed ID: 25145522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.
    Ionescu DD;
    Clin Drug Investig; 2009; 29(12):767-76. PubMed ID: 19888783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure control in treated hypertensive Middle Eastern patients: a post hoc analysis based on JNC8 definitions.
    Alhaddad IA; Hamoui O; Hammoudeh A; Mallat S
    Vasc Health Risk Manag; 2019; 15():35-46. PubMed ID: 30881006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels.
    Schmieder RE; Schmidt ST; Riemer T; Dechend R; Hagedorn I; Senges J; Messerli FH; Zeymer U
    Hypertension; 2014 Nov; 64(5):1067-72. PubMed ID: 25259741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
    Ostroumova OD; Garelik IA
    Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.
    Gueyffier F; Subtil F; Bejan-Angoulvant T; Zerbib Y; Baguet JP; Boivin JM; Mercier A; Leftheriotis G; Gagnol JP; Fauvel JP; Giraud C; Bricca G; Maucort-Boulch D; Erpeldinger S;
    J Hum Hypertens; 2015 Jan; 29(1):22-7. PubMed ID: 24739801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences in antihypertensive drug use and blood pressure control.
    Wang J; Jiang W; Sharma M; Wu Y; Li J; You N; Ding Z; Zhao X; Chen H; Tang H; Zhou X; Li X
    Postgrad Med J; 2019 Jun; 95(1124):295-299. PubMed ID: 31171709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Cushman WC; Ford CE; Einhorn PT; Wright JT; Preston RA; Davis BR; Basile JN; Whelton PK; Weiss RJ; Bastien A; Courtney DL; Hamilton BP; Kirchner K; Louis GT; Retta TM; Vidt DG;
    J Clin Hypertens (Greenwich); 2008 Oct; 10(10):751-60. PubMed ID: 19090876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.